PA
CRMD icon

Profund Advisors’s CorMedix CRMD Stock Holding History

Profund Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Sell
22,836
-246
-1% -$1.94K ﹤0.01% 1110
2026
Q1 		$157K Buy
23,082
+2,675
+13% +$19.8K 0.01% 1053
2025
Q4 		$237K Sell
20,407
-1,319
-6% -$14.6K 0.01% 1055
2025
Q3 		$253K Buy
21,726
+9,847
+83% +$119K 0.01% 844
2025
Q2 		$146K Sell
11,879
-601
-5% -$6.63K 0.01% 942
2025
Q1 		$76.9K Sell
12,480
-5,498
-31% -$56.9K ﹤0.01% 967
2024
Q4 		$146K Buy
+17,978
New +$180K 0.01% 1045

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Profund Advisors's CRMD Position: Q2 2026 in Review

Profund Advisors reduced its CorMedix (CRMD) stake by 1.1% in Q2 2026, selling an estimated $1.94K and leaving 22,836 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Profund Advisors first reported a position in CRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $253K in Q3 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Profund Advisors held 22,836 shares of CorMedix worth $179K as of Q2 2026.
  • Profund Advisors sold 246 CorMedix shares in Q2 2026, an estimated $1.94K.
  • CorMedix made up ﹤0.01% of Profund Advisors's portfolio in Q2 2026, its #1110 holding.
  • Profund Advisors first reported a position in CorMedix in Q4 2024 and has held it in 7 quarters since.
  • Profund Advisors's CorMedix position peaked at $253K in Q3 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.